A structural model of human ferroportin and of its iron binding site

FEBS Journal

Volumn 281, Issue 12, 2014, Pages 2851-2860

  Bonaccorsi Di Patti, Maria C ^a   Polticelli, Fabio ^b,c   Cece, Giovanna ^d   Cutone, Antimo ^a   Felici, Franco ^d   Persichini, Tiziana ^b   Musci, Giovanni ^d  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b ROMA TRE UNIVERSITY   (Italy)

^c INFN SEZIONE DI ROMA   (Italy)

^d UNIVERSITY OF MOLISE   (Italy)

Author keywords

Fpn; hemochromatosis; iron; major facilitator superfamily; molecular modelling

Indexed keywords

ASPARTIC ACID; FERROPORTIN; IRON;

ARTICLE; BINDING SITE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; HEK293 CELL LINE; IRON TRANSPORT; METAL BINDING; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN CONFORMATION; STRUCTURE ANALYSIS; WILD TYPE;

FPN; HEMOCHROMATOSIS; IRON; MAJOR FACILITATOR SUPERFAMILY; MOLECULAR MODELLING;

BINDING SITES; CATION TRANSPORT PROTEINS; ESCHERICHIA COLI PROTEINS; HEK293 CELLS; HEMOCHROMATOSIS; HUMANS; IRON; LIGANDS; MODELS, MOLECULAR; MUTATION; PROTEIN CONFORMATION;

EID: 84902665769     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.12825     Document Type: Article

References (35)

1. Ward DM, &, Kaplan J, (2012) Ferroportin-mediated iron transport: expression and regulation. Biochim Biophys Acta 1823, 1426-1433.
2. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, &, Kaplan J, (2004) Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306, 2090-2093.
3. Rice AE, Mendez MJ, Hokanson CA, Rees DC, &, Bjorkman PJ, (2009) Investigation of the biophysical and cell biological properties of ferroportin, a multipass integral membrane protein iron exporter. J Mol Biol 386, 717-732.
4. Liu XB, Yang F, &, Haile DJ, (2005) Functional consequences of ferroportin 1 mutations. Blood Cells Mol Dis 35, 33-46.
5. Gonçalves AS, Muzeau F, Blaybel R, Hetet G, Driss F, Delaby C, Canonne-Hergaux F, &, Beaumont C, (2006) Wild-type and mutant ferroportins do not form oligomers in transfected cells. Biochem J 396, 265-275.
6. De Domenico I, McVey Ward D, Langelier C, Vaughn MB, Nemeth E, Sundquist WI, Ganz T, Musci G, &, Kaplan J, (2007) The molecular mechanism of hepcidin-mediated ferroportin down-regulation. Mol Biol Cell 18, 2569-2578.
7. Qiao B, Sugianto P, Fung E, del-Castillo-Rueda A, Moran-Jimenez MJ, Ganz T, &, Nemeth E, (2012) Hepcidin-induced endocytosis of ferroportin is dependent on ferroportin ubiquitination. Cell Metab 15, 918-924.
8. De Domenico I, Nemeth E, Nelson JM, Phillips JD, Ajioka RS, Kay MS, Kushner JP, Ganz T, McVey Ward D, &, Kaplan J, (2008) The hepcidin binding site on ferroportin is evolutionarily conserved. Cell Metab 8, 146-156.
9. Preza GC, Ruchala P, Pinon R, Ramos E, Quiao B, Peralta MA, Sharma S, Waring A, Ganz T, &, Nemeth E, (2011) Minihepcidins are rationally designed small peptides that mimic hepcidin activity in mice and may be useful for the treatment of iron overload. J Clin Invest 121, 4880-4888.
10. Wallace DF, Harris JM, &, Subramaniam VN, (2010) Functional analysis and theoretical modeling of ferroportin reveals clustering of mutations according to phenotype. Am J Physiol Cell Physiol 298, C75-C84.
11. Le Gac G, Ka C, Joubrel R, Gourlaouen I, Lehn P, Mornon JP, Ferec C, &, Callebaut I, (2013) Structure-function analysis of the human ferroportin iron exporter (SLC40A1): effect of hemochromatosis type 4 mutations and identification of critical residues. Hum Mutat 34, 1371-1380.
12. Xu D, Zhang J, Roy A, &, Zhang Y, (2011) Automated protein structure modeling in CASP9 by I-TASSER pipeline combined with QUARK-based ab initio folding and FG-MD-based structure refinement. Proteins 79, 147-160.
13. Roy A, Kucukural A, &, Zhang Y, (2010) I-TASSER: a unified platform for automated protein structure and function prediction. Nat Protoc 5, 725-738.
14. Baker HM, Anderson BF, &, Baker EN, (2003) Dealing with iron: common structural principles in proteins that transport iron and heme. Proc Natl Acad Sci USA 100, 3579-3583.
15. Kovaleva EG, &, Lipscomb JD, (2008) Versatility of biological non-heme Fe(II) centers in oxygen activation reactions. Nat Chem Biol 4, 186-193.
16. De Domenico I, McVey Ward D, Bonaccorsi di Patti MC, Jeong SY, David S, Musci G, &, Kaplan J, (2007) Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin. EMBO J 26, 2823-2831.
17. De Domenico I, McVey Ward D, Nemeth E, Ganz T, Corradini E, Ferrara F, Musci G, Pietrangelo A, &, Kaplan J, (2006) Molecular and clinical correlates in iron overload associated with mutations in ferroportin. Haematologica 91, 1092-1095.
18. Schimanski LM, Drakesmith H, Merryweather-Clarke AT, Viprakasit V, Edwards JP, Sweetland E, Bastin JM, Cowley D, Chinthammitr Y, Robson KJH, et al,. (2005) In vitro functional analysis of human ferroportin (FPN) and hemochromatosis-associated FPN mutations. Blood 105, 4096-4102.
19. Girelli D, De Domenico I, Bozzini C, Campostrini N, Busti F, Castagna A, Soriani N, Cremonesi L, Ferrari M, Colombari R, et al,. (2008) Clinical, pathological, and molecular correlates in ferroportin disease: a study of two novel mutations. J Hepatol 49, 664-671.
20. Law CJ, Maloney PC, &, Wang DN, (2008) The ins and outs of major facilitator superfamily antiporters. Annu Rev Microbiol 62, 289-305.
21. Reyes N, Ginter C, &, Boudker O, (2009) Transport mechanism of a bacterial homologue of glutamate transporters. Nature 462, 880-885.
22. Detiveaud L, Island ML, Jouanolle AM, Ropert M, Bardou-Jaquet E, Le Lan C, Mosser A, Leroyer P, Deugnier Y, David V, et al,. (2013) Ferroportin diseases: functional studies, a link between genetic and clinical phenotype. Hum Mutat 34, 1529-1536.
23. Kumar H, Kasho V, Smirnova I, Finer-Moore JS, Kaback HR, &, Stroud RM, (2014) Structure of sugar-bound LacY. Proc Natl Acad Sci USA 111, 1784-1788.
24. Cremonesi L, Forni GL, Soriani N, Lamagna M, Fermo I, Daraio F, Galli A, Pietra D, Malcovati L, Ferrari M, et al,. (2005) Genetic and clinical heterogeneity of ferroportin disease. Br J Haematol 131, 663-670.
25. Letocart E, Le Gac G, Majore S, Ka C, Radio FC, Gourlaouen I, De Bernardo C, Ferec C, &, Grammatico P, (2009) A novel missense mutation in SLC40A1 results in resistance to hepcidin and confirms the existence of two ferroportin-associated iron overload diseases. Br J Haematol 147, 379-385.
26. Mayr R, Janecke AR, Schranz M, Griffiths WJH, Vogel W, Pietrangelo A, &, Zoller H, (2010) Ferroportin disease: a systematic meta-analysis of clinical and molecular findings. J Hepatol 53, 941-949.
27. Mayr R, Griffiths WJH, Hermann M, McFarlane I, Halsall DJ, Finkestedt A, Douds A, Davies SE, Janecke AR, Vogel W, et al,. (2011) Identification of mutations in SLC40A1 that affect ferroportin function and phenotype of human ferroportin iron overload. Gastroenterology 140, 2056-2063.
28. Fernandes A, Preza GC, Phung Y, De Domenico I, Kaplan J, Ganz T, &, Nemeth E, (2009) The molecular basis of hepcidin-resistant hereditary hemochromatosis. Blood 114, 437-443.
29. Khafizov K, Staritzbichler R, Stamm M, &, Forrest LR, (2010) A study of the evolution of inverted-topology repeats from LeuT-fold transporters using AlignMe. Biochemistry 49, 10702-10713.
30. Petrey D, Xiang Z, Tang CL, Xie L, Gimpelev M, Mitros T, Soto CS, Goldsmith-Fischman S, Kernytsky A, Schlessinger A, et al,. (2003) Using multiple structure alignments, fast model building, and energetic analysis in fold recognition and homology modeling. Proteins 53, 430-435.
31. Laskowski R, MacArthur M, Moss D, &, Thornton J, (1993) PROCHECK-a program to check the stereochemical quality of protein structures. J Appl Crystallogr 26, 283-291.
32. Zhang Y, &, Skolnick J, (2005) TM-align: a protein structure alignment algorithm based on the TM-score. Nucleic Acids Res 33, 2302-2309.
33. Bonaccorsi di Patti MC, Persichini T, Mazzone V, Polticelli F, Colasanti M, &, Musci G, (2004) Interleukin-1beta up-regulates iron efflux in rat C6 glioma cells through modulation of ceruloplasmin and ferroportin-1 synthesis. Neurosci Lett 363, 182-186.
34. Sears IB, O'Connor J, Rossanese OW, &, Glick BS, (1998) A versatile set of vectors for constitutive and regulated gene expression in Pichia pastoris. Yeast 14, 783-790.
35. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, &, Ferrin TE, (2004) UCSF Chimera-a visualization system for exploratory research and analysis. J Comput Chem 25, 1605-1612.